Denmark· DK-28105283713
Hydroxocobalamin "Alternova"
A hydroxocobalamin product containing hydroxocobalaminchloride, registered in Denmark by Alternova A/S. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Hydroxocobalamin is registered in 11 of 19 countries.
Countries holding a registration under ATC B03BA03 (hydroxocobalamin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Hydroxocobalamin · ATC B03BA03
11 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Hydroxocobalaminchloride
- Manufacturer
- Alternova A/S
- Country
- Denmark (DK)
- ATC code
- B03BA03
- ATC class
- Hydroxocobalamin
- Defined daily dose
- 20 mcg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105283713
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
40 interactions on record for hydroxocobalamin.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydroxocobalamin · interactions on record
40 records
- 2 moderate
- 38 info
Most severe, free to view
- ChloramphenicolJ01BA01moderate
- Arsenic trioxideL01XX27moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B03BA03
Hydroxocobalamin, as other registers publish it.
- United KingdomCobalin-H 1mg/1ml solution for injection ampoulesAdvanz Pharma
- FinlandCoheminOrion Corporation
- DenmarkCoheminOrion Corporation
- FinlandCohemin DepotOrion Corporation
- United StatesCyanokitBTG INTERNATIONAL INC.
- United KingdomCyanokit 2.5g powder for solution for infusion vialsSERB
- United KingdomCyanokit 2.5g powder for solution for infusion vialsImported (United States)
- United KingdomCyanokit 5g powder for solution for infusion vialsSERB
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4243f6b-4a64-4876-9d72-ede3b9251cb9 GET /v1/drugs/d4243f6b-4a64-4876-9d72-ede3b9251cb9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning",
"source": "dkma",
"strength": "1 mg/ml",
"auth_role": "DKMA",
"dk_drugid": "28105283713",
"substance": "Hydroxocobalaminchloride",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "41927"
}See everything about hydroxocobalamin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.